Biohit Launches Calprotectin Test For Diagnosis And Monitoring Of Inflammatory Bowel Diseases
3/24/2014 9:03:22 AM
Biohit Oyj launches a diagnostic test for the differentiation of inflammatory bowel disease IBD and irritable bowel syndrome (IBS) as well as monitoring of inflammatory bowel disease. The Calprotectin test will enhance Biohit's gastrointestinal diagnostic tests range. Biohit distributes the test to designated European, Middle East and Asian countries.
Help employers find you! Check out all the jobs and post your resume.
comments powered by